Y Intercept Hong Kong Ltd Makes New $744,000 Investment in Cardinal Health, Inc. $CAH

Y Intercept Hong Kong Ltd bought a new position in Cardinal Health, Inc. (NYSE:CAH) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,522 shares of the company’s stock, valued at approximately $744,000.

Several other hedge funds and other institutional investors also recently modified their holdings of CAH. Redhawk Wealth Advisors Inc. grew its stake in Cardinal Health by 0.5% in the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after buying an additional 48 shares in the last quarter. HF Advisory Group LLC lifted its position in shares of Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after acquiring an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. boosted its holdings in shares of Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares during the period. Generali Asset Management SPA SGR grew its position in shares of Cardinal Health by 11.0% in the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after purchasing an additional 51 shares in the last quarter. Finally, Stephens Inc. AR grew its position in shares of Cardinal Health by 0.9% in the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock valued at $1,223,000 after purchasing an additional 52 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.1%

Shares of CAH stock opened at $235.54 on Monday. The business has a 50-day moving average price of $212.35 and a two-hundred day moving average price of $213.05. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $243.21. The firm has a market cap of $55.16 billion, a P/E ratio of 36.01, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 31.50%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent research reports. TD Cowen increased their price objective on Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. William Blair assumed coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $249.13.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.